Glaxo gets OK to expand marketing of inhaler drug
GlaxoSmithKline plc says it has received US approval to sell its once-a-day respiratory inhaler Breo Ellipta for a new use in asthma patients ages 18 and older.
May 01, 2015, 03:16 AM IST
GlaxoSmithKline plc says it has received US approval to sell its once-a-day respiratory inhaler Breo Ellipta for a new use in asthma patients ages 18 and older.
May 01, 2015, 03:16 AM IST